Fact Sheet: President Donald J. Trump Announces First Deal to Bring Most-Favored-Nation Pricing to American Patients

Fact Sheet: President Donald J. Trump Announces First Deal to Bring Most-Favored-Nation Pricing to American PatientsKey Points:Access for States: All state Medicaid programs will gain access to MFN prices on Pfizer medicines, saving millions of dollars.Patient Discounts: Patients purchasing directly will see major reductions, including:Foreign Revenue & Innovation: Agreement requires Pfizer to repatriate increased foreign revenue resulting from U.S. trade policy, deliver MFN pricing on all new innovative medicines, and ensure deep discounts for American patients.Ending Global “Freeloading”:Fulfilling Promises:Takeaway:This deal marks the first time a major pharmaceutical company has agreed to MFN pricing, setting a precedent for lowering drug costs, protecting U.S. patients, and ending reliance on Americans to subsidize low drug prices abroad.